Bocouture 1 00 IU 1 Vial

Key Features:

• Botulinum neurotoxin type A blocks cholinergic transmission at the neuromuscular junction by inhibiting the release of acetylcholine
• Bocouture is free from complexing proteins

Treatment Areas:

• Glabellar frown lines
• Periorbital lines
• Horizontal forehead lines

Composition:

•  Botulinum toxin type A, free from complexing proteins. The additional ingredients are human albumin and sucrose.

Box Contents:

• Box contains one Bocouture 100iu vial

Contraindications of Bocouture:

• Hypersensitivity to the active substance or any of the excipients
• Generalised disorders of muscle activity (e.g. myasthenia gravis, Lambert- Eaton syndrome)
• Infection or inflammation at the proposed injection site

Who Should Not Use Bocouture?

• The injection of Bocouture is not recommended for patients with a history of aspiration or dysphagia
• Patients suffering from amyotrophic lateral sclerosis
• Patients with other diseases which result in peripheral neuromuscular dysfunction
• In targeted muscles that display pronounced weakness or atrophy

Storage:

• Keep at room temperature

Additional Information:

EMC: https://www.medicines.org.uk/emc/product/7418/smpc

Patient Information Leaflet: https://www.medicines.org.uk/emc/files/pil.7418.pdf